NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Jupiter Neurosciences, Inc. Common Stock Share Price Chart

O H L

Jupiter Neurosciences, Inc. Common Stock Performance Overview

Days Range
$3.05Low
$3.05High

Markets Today

Previous Close$3.01
Open$3.05
Volume2,729
Day's Range$3.05 - $3.05
52W RangeNA
Market Cap$3.86 M

Historical Performance

1M Returns-40.51
3M Returns-83.14
6M Returns-89.15
1Y Returns-97.19
5Y ReturnsNA
10Y ReturnsNA

Jupiter Neurosciences, Inc. Common Stock Fundamentals

Market Cap$3.86 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$21.80 K
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-8.14 M
Profit Margin-39662.77
Market Cap$3.86 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$21.80 K
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-8.14 M
Profit Margin-39662.77

Jupiter Neurosciences, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$21.80 K$18.65 K$24.25 K
Gross Profit +$0$0$0$17.57 K$14.29 K$21.06 K
Operating Income -$1.54 M-$2.26 M-$2.30 M-$2.81 M-$1.96 M-$2.74 M
EBITDA -$1.35 M-$2.07 M-$2.10 M-$2.62 M-$1.77 M-$2.55 M
Interest Expense -$1.23 K-$1.14 K-$1.19 K-$62.46 K-$118.64 K-$90.62 K
Depreciation $189.04 K$191.14 K$193.24 K$193.24 K$189.04 K$191.14 K
Income Before Tax -$1.53 M-$2.25 M-$2.29 M-$2.58 M-$2.06 M-$2.27 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$1.53 M-$2.25 M-$2.29 M-$2.58 M-$2.06 M-$2.27 M
Net Profit Margin ----11814.24%-11054.89%-9380.89%

Jupiter Neurosciences, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $3.31 K$3.48 K$3.43 K$46$3.63 K$66
Reserve & Surplus -$27.55 M-$29.80 M-$32.09 M-$34.67 M-$36.73 M-$39.00 M
Non-Current Liabilities $8.51 K$0$0$0$0$205.07 K
Current Liabilities $1.89 M$2.63 M$2.52 M$7.40 M$6.73 M$3.88 M
Total Liabilities $1.90 M$2.63 M$2.52 M$7.40 M$6.73 M$4.08 M
Fixed Assets $0$0$0$0$0$0
Current Assets $3.61 M$2.82 M$1.63 M$4.82 M$3.41 M$2.55 M
Total Assets $4.96 M$3.97 M$2.58 M$5.56 M$3.95 M$3.72 M

Jupiter Neurosciences, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$1.53 M-$2.25 M-$2.29 M-$2.58 M-$2.06 M-$2.27 M
Operating Cash Flow -$1.06 M-$828.22 K-$1.15 M-$2.37 M-$1.43 M-$2.29 M
Investing Cash Flow $0$0$0$0$0$0
Financing Cash Flow $0$0$0$5.43 M$5.51 K$1.45 M
Change in Cash -$1.06 M-$828.22 K-$1.15 M$3.07 M-$1.43 M-$840.88 K

Jupiter Neurosciences, Inc. Common Stock Return Calculator

The Jupiter Neurosciences, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About Jupiter Neurosciences, Inc. Common Stock

Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol, which has many potential indications. In the larger disease areas, which are targeting Parkinson's Disease. The group is presently in the process of conducting a Phase IIa clinical trial in Parkinson's Disease. The company operates through two reportable segments: premium nutritional supplements and pharmaceutical operations focused on drug candidates for CNS and rare orphan diseases. It generates the majority of its revenue from Premium Nutritional Supplements, which includes commercialization and sales of the Company's Nugevia product line.

FAQs

Jupiter Neurosciences, Inc. Common Stock (JUNS) share price as of September 18, 2026 is $2.95. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Jupiter Neurosciences, Inc. Common Stock (JUNS) Share by opening an international trading account with Angel One.
Purchasing Jupiter Neurosciences, Inc. Common Stock (JUNS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Jupiter Neurosciences, Inc. Common Stock (JUNS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Jupiter Neurosciences, Inc. Common Stock (JUNS) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Jupiter Neurosciences, Inc. Common Stock on September 18, 2026, is $3.86 M.
Jupiter Neurosciences, Inc. Common Stock operates in the null sector, specifically in the null industry.
In order to invest in Jupiter Neurosciences, Inc. Common Stock (JUNS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91